''The KPMG Tech Growth team are continually looking to engage with and support exciting businesses with excellent potential. We are therefore delighted to have the opportunity, through workshops and mentoring, of working with the BioStars businesses as part of the broad package of support that the programme provides'' Technology Sector Team KPMG
“.. We’re therefore delighted to be partnering with the expanded programme in 2017, so that we can help the next round of scientists and entrepreneurs turn their scientific ideas into marketable products” Peter Silcock Patent Attorney and Partner JA Kemp
"One of BD’s key external innovation initiatives includes identifying transformation startups that combine cutting edge technology, 21st century business models and relentless entrepreneurs. We are therefore excited to be a first time partner with BioStars to source innovative startups..." Strategic Technology Partnerships Team Becton Dickinson Technology & Innovation
- 22 December 2017 An open letter: Farewell 2017, you've been good to us!!
- December 21, 2017 Are you up for the challenge? PanaceaStars 2018 Accelerator is now calling on applications!
- March 16, 2016 BioStars 2015-2016 Grand Finale - Oxford, LMH 16.03.16
- March 31, 2016 BREAKING BOTTLENECKS IN DRUG DISCOVERY AND DEVELOPMENT
- March 31, 2016 CRISPR-CAS9 THERAPEUTICS: A TECHNOLOGY OVERVIEW
Since the founding of Panacea Innovation, we have been privileged to interact with the best minds in Oxford, Cambridge, London and beyond. From academia, industry, finance, legal services, and, crucially to us, the sci-entrepreneurs; our partners and collaborators have aced it. The support and fe....get more info
PanaceStars 2018 is here! Do you want to turn your science into a life-changing product? Do you think you have what it takes to become a sci-entrepreneur? Come and join PanaceaStars! The call is now open to brilliant ideas across our three themes: Healthcare and Life Sciences (Bio....get more info
The Grand Finale of the BioStars 2015 edition, hosted at the spectacular Deneke Hall of Lady Margaret Hall, University of Oxford, had more than 150 guests, among which the shorlisted teams. The judging panel included Paul-Peter Tak (Senior Vice President R&D Pipeline at GSK), Graeme Mart....get more info
Despite years of effort and advances in technology and data mining, bringing a drug from bench to bedside remains a costly, complex and time-consuming process with no guarantee of success. According to a recent report by Pharmaceutical Research and Manufacturers of America, “Biophar....get more info
In a controversial paper published in the journal Protein & Cell earlier this year, Chinese scientists at Sun Yat-sen University reported the world’s first genomic editing of human embryos (1). Using genomic editing technology know....get more info